Company intelligence / Profile preview

OrderlyMeds

Scottsdale, Arizona, United States

Ownership: Private
Development stage: Other

Overview

OrderlyMeds is a telehealth company focused on providing accessible medical weight loss solutions through a digital-first platform. The company specializes in prescribing and delivering GLP-1 receptor agonists, specifically compounded Semaglutide and Tirzepatide, to patients across the United States. Their service model integrates online medical consultations, prescription fulfillment via licensed compounding pharmacies, and ongoing nutritional and fitness coaching. By leveraging a subscription-based pricing structure, OrderlyMeds aims to lower the barriers to entry for chronic weight management treatments.

Therapeutic areas: Endocrinology
Modalities: Peptides
Industry: Non-Academic Healthcare

Partnerships

Hallandale PharmacyRed Rock Pharmacy

Beyond the preview

Go deeper on OrderlyMeds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrderlyMeds.

Explore the full profile